Clinical trial of adjuvant therapy combination shows improved recurrence-free survival in liver cancer patients

An international randomized controlled trial, advised by a steering committee co-led by a senior clinician-scientist from the National Cancer Centre Singapore and Duke-NUS Medical School, Singapore, has reported that the combination therapy of atezolizumab and bevacizumab in the adjuvant setting is safe and effective in reducing cancer recurrence in patients with the primary liver cancer, hepatocellular carcinoma (HCC), at high risk for recurrence after curative intent resection or ablation.

Speed at which consent judgements are being awarded worry Fube

By NATION REPORTER

CHILUBI member of Parliament Mulenga Fube has expressed worry at the speed at which compensations for wrongful detentions are being awarded to ruling party and sympathizers through consent judgements at the expense of old cases.

This content is locked

This is exclusive material. To read full story, click on register and choose one of the premium subscriptions to view this content. Login if you are already a premium user.


Diagnosis and management of postoperative wound infections in the head and neck region

In everyday clinical practice at a department for oral and maxillofacial surgery, a large number of surgical procedures in the head and neck region take place under both outpatient and inpatient conditions. The basis of every surgical intervention is the patient’s consent to the respective procedure. Particular attention is drawn to the general and operation-specific risks.